Targeted RFA 2019

Movember Translation Acceleration Grant to improve patient outcomes and treatment planning with advanced imaging

With this funding opportunity announcement, Prostate Cancer Canada (PCC) invites members of the prostate cancer research community to collaboratively participate in a multi-stage process to submit one (1) application for an investigator-initiated Translational Acceleration Grant (TAG).
New imaging modalities are increasing our ability to detect low volume prostate cancer metastases. The project funded by this mechanism will explore how advanced imaging such as PET, CT and mpMRI, together with appropriate treatment for men with advanced prostate cancer can lead to better outcomes.
A multidisciplinary approach is required and the Movember TAG application will consist of independent investigators based in multiple institutions. PCC will only consider a project that is focused completely on prostate cancer.

This request for applications (RFA) is a multi-step process:
  • Individuals submit an Expression of Interest to participate in developing a proposal. Selected individuals will be brought together with the intention of collaborating.
  • As a team, submit an application that will have the greatest potential to demonstrate the value of incorporating advanced imaging modalities into prostate cancer management in Canada and abroad by designing and carrying out a prospective clinical trial that evaluates patient outcomes following image-guided treatment planning.
This opportunity is awarded by Prostate Cancer Canada and proudly funded by the Movember Foundation.

Award amount: up to $3M over 3 years
 Movember logo-(1).jpg
Key dates:
Expression of Interest Letters from Individuals Deadline: June 27, 2019
Invitations extended to Individuals to attend Planning Meeting: July 12, 2019
Planning Meeting in Toronto: September 23, 2019
Team Registration Deadline: October 15, 2019
Full Application Deadline: November 12, 2019
Review Panel Meeting and Reverse Site Visit in Toronto: December 9, 2019
Funding start date: January 1, 2020

Links to:
Program Description
Frequently Asked Questions
 

Donate Now!






Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive